e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Early diagnosis and effectiveness of disease management in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnosis of airway obstruction: A comparison between the GLI 2012 reference equations, the NHANES III reference equations and the fixed cut-off for FEV
1
/FVC
B. Chomé, J. Vandevoorde (Brussels, Belgium)
Source:
Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Session:
Early diagnosis and effectiveness of disease management in primary care
Session type:
Thematic Poster Session
Number:
2416
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Chomé, J. Vandevoorde (Brussels, Belgium). Diagnosis of airway obstruction: A comparison between the GLI 2012 reference equations, the NHANES III reference equations and the fixed cut-off for FEV
1
/FVC. Eur Respir J 2013; 42: Suppl. 57, 2416
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The effect of adopting new GLI-2012 spirometric reference values on airflow limitation GOLD classification
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015
Concordance among GOLD, NICE and LLN criteria in the spirometry diagnosis of airflow obstruction
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction?
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Airway obstruction by GOLD and ATS/ERS2005 criteria in Caucasian American pulmonary laboratory patients using NHANESIII and ERS/GLI12 prediction equations
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014
Severity of airflow obstruction using NHANESIII versus ERS/GLI12 prediction equations in Caucasian American pulmonary laboratory patients
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014
Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
The combination of forced expiratory tracheal noise time and band pass energy divides patients with bronchial obstruction into two clusters
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Measuring lung function in asthmatic children: A spirometry and forced oscillation technique (FOT) comparison
Source: International Congress 2016 – Highlights in primary ciliary dyskinesia and asthma in childhood
Year: 2016
Usefulness of FEV1/SVC to uncover airflow obstruction in subjects with preserved FEV1/FVC
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016
The FEV
1
/TLC ratio: Can it differentiate between normal subjects and patients with airflow obstruction and restrictive ventilatory defects - a preliminary analysis?
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013
The prevalence of patients with normal post-bronchodilator spirometry that fulfil the criteria for GOLD mild COPD using ECCS predicted equations
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019
Use FEV6 and FEV1/FEV6 as alternative indicators in the diagnosis of bronchial obstruction in primary care
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
Five FEV1 adjustment methods for grading airway obstruction severity in USA Caucasian patients
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015
Applicability of the global lung initiative (GLI) spirometric reference values for northern Sweden
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
The global Lund function initiative (GLI) reference values do not reflect lung function in the Nordic countries
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Fixed ratio or lower limit of normal for the FEV1/VC ratio: Relation to symptoms and extended lung function tests
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Small airways function in children with mild asthma and normal FEV
1
Source: Annual Congress 2013 –New perspectives of lung function assessment in children
Year: 2013
Differences in functional impairment diagnosis using global lung initiative (GLI) predictive values for spirometry
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
Source: Eur Respir J 2012; 40: 1324-1343
Year: 2012
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept